CALGARY, Aug. 26, 2019 /CNW/ - Nanalysis
Scientific Corp. (the "Company" or "Nanalysis",
TSX-V:NSCI), is pleased to announce the world's first ever 100 MHz
compact NMR device with unprecedented performance metrics including
superior resolution and sensitivity, plus over 25% better signal
dispersion than any competing compact NMR device on the market.
The launch of this new high-end benchtop product is based on the
market demand identified from five years of customer feedback and
acquiring data from thousands of samples from around the world.
Customers in the pharmaceutical, nutraceutical, law enforcement,
and agrochemical industries require affordable, accessible and
automatable compact NMR devices for their R&D, chemical
extraction/processing plants and QA/QC processes. Nanalysis'
NMReady-60™, already deployed in labs around the world, meets many
customer requirements and the new 100MHz device opens the door to
industries and processes that were not being served with an
affordable NMR tool.
Nanalysis CEO Sean Krakiwsky
states: "I am incredibly proud of our marketing and product
development groups for identifying the market-driven need for this
new product and for the world class development effort leading to
this launch. We expect tremendous demand for this high-performance
model, as we lead the global NMR 'appification'
movement. Customers no longer have to spend millions of TCO dollars
and endless liquid helium on high-field NMR installations, to meet
most existing and many new NMR testing applications needs. For
decades, the evolution of NMR was towards bigger, more expensive
hardware, whereas Nanalysis is focused on smaller and smarter NMR
solutions. Additionally, compact NMR will replace outdated,
multi-step, expensive, sample-destructive, environmentally
unfriendly testing in many industrial QA/QC processes where other
types of benchtop analytical instruments are currently used. Of
course, we are not doing this alone - our partners in the compact
NMR ecosystem are a critical part of this NMR 'appification'
movement."
Dr. Rob O'Brien, CEO of Supra
R&D, an innovative analytical services company, states:
"Nanalysis has shown true global leadership in the compact NMR
space with this product launch. Supra R&D is excited to offer
this to our customers, particularly those in the nutraceutical and
cannabis industries. At Supra R&D, we are at the forefront of
offering innovative analytical services and establishing testing
standards with international regulatory bodies, such as ASTM and
AOAC, for quality control of consumer products in these industries.
Hardware partners such as Nanalysis are critical to our
success."
Dr. Samuli-Petrus Korhonen,
President of NMR Solutions, an emerging leader in NMR Software as a
Service (SasS), states: "Our software incorporates quantum
mechanical modeling to increase the effective resolution of compact
NMR data. 100 MHz hardware is at the sweet spot of our innovative
model-based approach, allowing for broader penetration of the
market and maximization of value for our customers. NMR Solutions
is focused on cloud-based SaaS in partnership with companies like
Nanalysis, as we continue to change the way people think about NMR,
making it simpler, more useful, and less expensive."
Nanalysis is accepting advance orders for the 100 MHz product
immediately and expects to ship the first production units to
customers by Q1 2020.
About Nanalysis Scientific Corp. (TSX-V:NSCI,
FRA:1N1)
Nanalysis recently listed on the TSX Venture Exchange in
Canada with ticker symbol of
'NSCI'. The company develops and manufactures portable Nuclear
Magnetic Resonance (NMR) spectrometers or analyzers for laboratory
and industrial instrumentation markets. The NMReady-60™ was the
first fully featured portable NMR spectrometer in a single compact
enclosure requiring no liquid helium or any other cryogens, and the
company has followed-up that initial offering with new products and
continues to have a strong innovation pipeline.
Nanalysis devices are used by chemical professionals in many
industries (oil and gas, chemical, mining, pharma, biotech, flavor
and fragrances, agrochemicals, etc.) as well as numerous government
and university labs around the world. The company continues to
exploit new global market opportunities with partners and
independently.
Notice regarding Forward Looking Statements and Legal
Disclaimer
This news release contains certain "forward-looking statements"
within the meaning of such statements under applicable securities
law. Forward-looking statements are frequently characterized by
words such as "anticipates", "plan", "continue", "expect",
"project", "intend", "believe", "anticipate", "estimate", "may",
"will", "potential", "proposed", "positioned" and other similar
words, or statements that certain events or conditions "may" or
"will" occur. These statements are only predictions. Various
assumptions were used in drawing the conclusions or making the
projections contained in the forward-looking statements throughout
this news release. Forward-looking statements are based on the
opinions and estimates of management at the date the statements are
made and are subject to a variety of risks and uncertainties and
other factors that could cause actual events or results to differ
materially from those projected in the forward-looking statements.
The Corporation is under no obligation, and expressly disclaims any
intention or obligation, to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
The TSX Venture Exchange or other regulatory authority has not
reviewed, approved or disapproved the contents of this press
release. We seek safe harbor.
SOURCE Nanalysis Scientific Corp.